Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China.
Department of Obstetrics and Gynecology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
J Obstet Gynaecol Res. 2021 Nov;47(11):3943-3950. doi: 10.1111/jog.14988. Epub 2021 Aug 18.
To compare the survival outcome between radical hysterectomy and simple hysterectomy with radiation therapy in patients with stage II endometrial cancer.
This is a retrospective cohort study based on the SEER database from January 1, 1988 to December 31, 2015.
Of 577 patients were enrolled in the study, 117 patients received radical hysterectomy and 460 patients received simple hysterectomy combined with vaginal brachytherapy. All patients received external beam radiation therapy after the surgery. The median follow-up duration was 82.77 ± 1.44 months. No differences were found on the baseline information between two groups. Both the 5-year overall survival (62.31% vs. 78.48%, p < 0.001) and 5-year cause-specific survival (74.60 vs. 85.38%, p = 0.01) were shorter in radical hysterectomy than in simple hysterectomy combined with vaginal brachytherapy group. However, the positive outcomes were further validated in patients with high-risk endometrial cancer, not in patients with grade 1-2 low-risk endometrial cancer both on cause-specific survival and overall survival. In patients with grade 3 low-risk endometrial cancer, the tendency was only found with lower overall survival not cause-specific survival.
This study revealed that in patients' high-risk stage II endometrial cancer, radical hysterectomy was associated with shorter survival outcome than simple hysterectomy combined with vaginal brachytherapy.
比较 II 期子宫内膜癌患者根治性子宫切除术与单纯子宫切除术联合放射治疗的生存结局。
这是一项基于 SEER 数据库的回顾性队列研究,时间范围为 1988 年 1 月 1 日至 2015 年 12 月 31 日。
本研究共纳入 577 例患者,其中 117 例患者接受根治性子宫切除术,460 例患者接受单纯子宫切除术联合阴道近距离放疗。所有患者在手术后均接受外照射放疗。中位随访时间为 82.77±1.44 个月。两组患者的基线资料无差异。根治性子宫切除术组的 5 年总生存率(62.31%比 78.48%,p<0.001)和 5 年疾病特异性生存率(74.60%比 85.38%,p=0.01)均低于单纯子宫切除术联合阴道近距离放疗组。然而,在高危子宫内膜癌患者中,这种积极的结果得到了进一步验证,在 1-2 级低危子宫内膜癌患者中,无论是在疾病特异性生存还是总生存方面,均未得到证实。在 3 级低危子宫内膜癌患者中,仅发现总生存率较低而疾病特异性生存率无差异的趋势。
本研究表明,在高危 II 期子宫内膜癌患者中,根治性子宫切除术与单纯子宫切除术联合阴道近距离放疗相比,生存结局较差。